1.13Biomarkers and TestingDeep Dive2,300 words - 12 min read
Biomarkers & Testing — IQ Healthspan Dashboard-style visualization of key longevity biomarkers including ApoB, hsCRP, HbA1c, and VO2max. LONGEVITY BIOMARKER DASHBOARD ApoB Apolipoprotein B 58 mg/dL ✓ Optimal hsCRP Inflammation marker 0.4 mg/L ✓ Optimal HbA1c 3-month glucose average 5.2 % ✓ Optimal Fasting Insulin Insulin resistance proxy 12 uIU/mL ⚡ Suboptimal Vitamin D 25-OH Vitamin D 34 ng/mL ⚡ Below optimal VO₂max Cardiorespiratory fitness 48 mL/kg/min ◎ Good BIOMARKERS & TESTING Standard ranges vs. longevity-optimal targets IQ HEALTHSPAN

Uric Acid: The Overlooked Metabolic Biomarker Linking Fructose, Gout, and Cardiovascular Disease

Uric acid is the final product of purine metabolism in humans — produced from the breakdown of adenine and guanine nucleotides from DNA and RNA turnover, and from dietary purines. Elevated uric acid (hyperuricemia) causes gout, but its longevity relevance extends far beyond joint inflammation: it is independently associated with hypertension, insulin resistance, kidney disease, and cardiovascular mortality through mechanisms that go well beyond urate crystal deposition.

Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Oct 26, 2026
Published
Apr 8, 2026
Updated
✓ Cited Sources
Key Takeaways
  • Uric acid is generated from purine catabolism via the enzyme xanthine oxidase — the same enzyme that generates superoxide radical as a byproduct. High uric acid therefore co-occurs with high xanthine oxidase activity and oxidative stress, making it both a biomarker and a contributor to endothelial dysfunction and inflammatory pathology.
  • The fructose-uric acid connection is one of the most important in metabolic medicine: fructose metabolism in the liver uniquely generates uric acid (via AMP deamination during the ATP-depleting phosphorylation of fructose by fructokinase) in addition to de novo lipogenesis products. Sugar-sweetened beverages are the primary dietary driver of elevated uric acid in modern populations.
  • Optimal uric acid for longevity purposes is below 5.5 mg/dL in both men and women — below the standard 'high normal' cutoff. The risk of hyperuricemia-associated cardiovascular and metabolic outcomes increases progressively above 5.5 mg/dL, with dramatic elevation above 7.0 mg/dL (the supersaturation threshold for monosodium urate crystal formation).
  • The CARDIA study and multiple subsequent analyses have established that elevated uric acid in young adults (20s and 30s) predicts incident hypertension, type 2 diabetes, and cardiovascular events over the following decades — independent of traditional risk factors. Uric acid is not merely a downstream consequence of metabolic disease; Mendelian randomization studies support a causal contribution to hypertension.
  • The most effective dietary interventions for reducing uric acid: eliminate sugar-sweetened beverages and high-fructose corn syrup (the most potent uric acid dietary drivers), reduce alcohol (particularly beer and spirits — both raise uric acid via adenosine triphosphate degradation and reduced renal urate excretion), reduce red meat and shellfish (high in purines), and increase adequate hydration to support renal urate excretion.

Uric acid receives attention in clinical medicine primarily when it produces gout — the painful acute arthritis caused by monosodium urate crystal deposition in joints when serum uric acid exceeds approximately 6.8 mg/dL (the solubility threshold). But the longevity-relevant story of uric acid extends well beyond gout. Hyperuricemia is an early metabolic derangement that precedes hypertension, insulin resistance, and cardiovascular disease by years to decades — not merely as a biomarker of metabolic dysfunction, but through causal mechanisms that include endothelial dysfunction, renin-angiotensin system activation, and mitochondrial oxidative stress.1

Uric Acid Biology: Production and Clearance

Purines — adenine and guanine — are the nitrogen-containing bases of DNA and RNA. Their catabolism produces hypoxanthine and xanthine, which are converted to uric acid by the enzyme xanthine oxidase. Humans and great apes lack the enzyme uricase (urate oxidase) that converts uric acid to the more soluble allantoin — a loss-of-function mutation that occurred approximately 15 million years ago and produces much higher circulating uric acid than is found in most mammals. This evolutionary quirk makes humans uniquely susceptible to hyperuricemia and gout.2

Uric acid is cleared primarily by the kidneys (approximately 70 percent) and gut (approximately 30 percent). Renal urate handling involves glomerular filtration followed by proximal tubule reabsorption (via URAT1 transporter) and secretion (via ABCG2). Most hyperuricemia in adults is caused by underexcretion (90 percent of cases) rather than overproduction — the result of reduced renal urate clearance driven by insulin resistance (insulin reduces renal urate excretion), dehydration, medications (particularly thiazide diuretics and low-dose aspirin), and genetic variation in urate transporters.

The Fructose Connection

Fructose metabolism is uniquely linked to uric acid production through a mechanism distinct from glucose or fat metabolism. When fructose is phosphorylated by fructokinase in the liver, it rapidly depletes hepatocyte ATP — because fructokinase lacks the feedback inhibition that regulates hexokinase (the glucose phosphorylating enzyme). ATP depletion produces AMP, which is deaminated to IMP and then degraded to hypoxanthine and ultimately uric acid. This ATP-depleting pathway is activated by every high-dose fructose exposure — explaining why sugar-sweetened beverages (which deliver large fructose loads rapidly) consistently elevate uric acid in intervention trials. A single 600 mL sugar-sweetened beverage can transiently raise serum uric acid by 1-2 mg/dL.3

Uric Acid and Hypertension: Causal Evidence

Uric acid may be a cause of hypertension rather than merely a consequence — a causal mechanism supported by multiple lines of evidence. In animal models, induction of hyperuricemia produces hypertension that reverses when uric acid is lowered. In pediatric studies, hyperuricemia in adolescents precedes hypertension development. Mendelian randomization analyses using genetic variants in urate transporter genes as instruments find that genetically predicted higher uric acid causally elevates blood pressure. The proposed mechanism: uric acid stimulates renin-angiotensin system activation, impairs endothelial nitric oxide synthesis, and promotes afferent arteriolar vasoconstriction in the kidney — all of which raise blood pressure.4

Optimizing Uric Acid

For most adults with elevated uric acid below the gout threshold (6.8 mg/dL), dietary and lifestyle interventions are the primary approach. The most impactful: Eliminate sugar-sweetened beverages (the most potent dietary uric acid driver), reduce alcohol (particularly beer and spirits), increase hydration (dehydration concentrates urate and reduces renal excretion), achieve and maintain healthy weight (insulin resistance is the dominant driver of underexcretion), reduce dietary purines from red meat and shellfish (though this has modest effects compared to eliminating SSBs). For uric acid consistently above 7-8 mg/dL with metabolic risk factors, pharmaceutical urate-lowering therapy (allopurinol, febuxostat) may be appropriate in discussion with a physician.5

References

  1. 1Feig DI, et al. "Uric acid and cardiovascular risk." NEJM. 2008;359(17):1811-1821. [PubMed]
  2. 2Johnson RJ, et al. "Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?" Journal of Comparative Physiology B. 2009;179(1):67-76. [PubMed]
  3. 3Nakagawa T, et al. "A causal role for uric acid in fructose-induced metabolic syndrome." American Journal of Physiology. 2006;290(3):F625-631. [PubMed]
  4. 4Borghi C, et al. "Serum uric acid and the risk of cardiovascular and renal disease." Journal of Hypertension. 2015;33(9):1729-1741. [PubMed]
  5. 5Choi HK, et al. "Purine-rich foods, dairy and protein intake, and the risk of gout in men." NEJM. 2004;350(11):1093-1103. [PubMed]
Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Derek Giordano is the founder and editor of IQ Healthspan. Every article is independently researched and sourced to peer-reviewed scientific literature with numbered citations readers can verify. Derek has spent over a decade synthesizing longevity research, translating complex clinical and preclinical findings into accessible, evidence-based guidance. IQ Healthspan maintains no supplement brand partnerships, affiliate relationships, or financial conflicts of interest.

All Claims Sourced to Peer-Reviewed Research

Readers can verify via numbered citations

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your health. Read full medical disclaimer →